Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives

被引:0
作者
Philipp Backhaus
Benjamin Noto
Nemanja Avramovic
Lena Sophie Grubert
Sebastian Huss
Martin Bögemann
Lars Stegger
Matthias Weckesser
Michael Schäfers
Kambiz Rahbar
机构
[1] University Hospital Münster,Department of Nuclear Medicine
[2] European Institute for Molecular imaging (EIMI),Gerhard Domagk Institute for Pathology
[3] University of Münster,Department of Urology
[4] University Hospital of Münster,undefined
[5] University Hospital Münster,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2018年 / 45卷
关键词
Prostate cancer; PSMA; Prostate-specific membrane antigen; Endothelium; PET/CT; Angiogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:860 / 877
页数:17
相关论文
共 50 条
  • [31] Current Status and Future Perspectives of Androgen Receptor Inhibition Therapy for Prostate Cancer: A Comprehensive Review
    Kim, Tae Jin
    Lee, Young Hwa
    Koo, Kyo Chul
    BIOMOLECULES, 2021, 11 (04)
  • [32] Drug development for metastatic castration-resistant prostate cancer: current status and future perspectives
    Lassi, Kiran
    Dawson, Nancy A.
    FUTURE ONCOLOGY, 2011, 7 (04) : 551 - 558
  • [33] Radionuclide therapy targeting PSMA for the treatment of metastatic prostate cancer: Current point of view and ways of improvement
    Giraudet, A. L.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2019, 43 (03): : 275 - 279
  • [34] Prostate-specific membran antigen targeting positron emission tomography (PSMA-PET) in prostate cancer in France in 2023: Current use and perspectives
    Chanchou, M.
    Robin, P.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2023, 47 (05): : 258 - 265
  • [35] Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy
    Umbricht, Christoph A.
    Benesova, Martina
    Schibli, Roger
    Muller, Cristina
    MOLECULAR PHARMACEUTICS, 2018, 15 (06) : 2297 - 2306
  • [36] Circulating long non-coding RNAs in cancer: current status and future perspectives
    Qi, Peng
    Zhou, Xiao-yan
    Du, Xiang
    MOLECULAR CANCER, 2016, 15
  • [37] Immunotherapy in prostate cancer: current state and future perspectives
    Handa, Shivani
    Hans, Bandhul
    Goel, Shokhi
    Bashorun, Hafis O.
    Dovey, Zach
    Tewari, Ashutosh
    THERAPEUTIC ADVANCES IN UROLOGY, 2020, 12
  • [38] Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives
    Ansari, Mohammad Azam
    Thiruvengadam, Muthu
    Venkidasamy, Baskar
    Alomary, Mohammad N.
    Salawi, Ahmad
    Chung, Ill-Min
    Shariati, Mohammad Ali
    Rebezov, Maksim
    SEMINARS IN CANCER BIOLOGY, 2022, 86 : 678 - 696
  • [39] Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives
    Volpe, Fabio
    Nappi, Carmela
    Piscopo, Leandra
    Zampella, Emilia
    Mainolfi, Ciro Gabriele
    Ponsiglione, Andrea
    Imbriaco, Massimo
    Cuocolo, Alberto
    Klain, Michele
    CANCERS, 2023, 15 (19)
  • [40] Scoring systems of quantitative bone scanning in prostate cancer: historical overview, current status and future perspectives
    Zafeirakis, Athanasios
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2014, 17 (02): : 136 - 144